Citation Impact
Citing Papers
Body Fluid Cytokine Levels in Mild Cognitive Impairment and Alzheimer’s Disease: a Comparative Overview
2014
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Analysis of microRNA and Gene Expression Profiles in Multiple Sclerosis: Integrating Interaction Data to Uncover Regulatory Mechanisms
2016
The role of liquid–liquid phase separation in aggregation of the TDP-43 low-complexity domain
2019 Standout
Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes
2020 Standout
Opposing effects of progranulin deficiency on amyloid and tau pathologies via microglial TYROBP network
2017
Genetics of Frontotemporal Lobar Degeneration
2012
Ageing as a risk factor for neurodegenerative disease
2019 Standout
Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases
2015 Standout
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
2014 Standout
Decoding ALS: from genes to mechanism
2016 StandoutNature
Immune attack: the role of inflammation in Alzheimer disease
2015 Standout
A Meta-Analysis of Cytokines in Alzheimer's Disease
2010
Elevated levels of plasma brain derived neurotrophic factor in rapid cycling bipolar disorder patients
2014
Fusobacterium nucleatum: a commensal-turned pathogen
2015 Standout
Myasthenia gravis
2019 Standout
Genetics of primary progressive multiple sclerosis
2014
“New Old Pathologies”: AD, PART, and Cerebral Age-Related TDP-43 With Sclerosis (CARTS)
2016
MicroRNAs as Potential Circulating Biomarkers for Amyotrophic Lateral Sclerosis
2014
Biomarkers for Alzheimer Disease: Classical and Novel Candidates’ Review
2017
Interleukin-6, a mental cytokine
2011
<p>Reactive Oxygen Species: Drivers of Physiological and Pathological Processes</p>
2020 Standout
Biomarkers in multiple sclerosis
2015
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
2020 Standout
Age-Associated mRNA and miRNA Expression Changes in the Blood-Brain Barrier
2019 StandoutNobel
Alzheimer's disease
2017 Standout
Circulating microRNAs as potential biomarkers in myasthenia gravis patients
2017
Serum antibodies to periodontal pathogens are a risk factor for Alzheimer's disease
2012
The neuropathological diagnosis of Alzheimer’s disease
2019 Standout
Current concepts in the diagnosis and management of cytokine release syndrome
2014 Standout
National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
2012 Standout
Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease.
2015
Multiple Sclerosis
2018 Standout
Inflammation as a central mechanism in Alzheimer's disease
2018 Standout
How neuroinflammation contributes to neurodegeneration
2016 StandoutScience
Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases
2015 Standout
The Role of Hydrogen Peroxide in Redox-Dependent Signaling: Homeostatic and Pathological Responses in Mammalian Cells
2018
Massive gliosis induced by interleukin‐6 suppresses Aβ deposition in vivo: evidence against inflammation as a driving force for amyloid deposition
2009
Works of Chiara Villa being referenced
DCUN1D1is a risk factor for frontotemporal lobar degeneration
2009
Novel exon 1 progranulin gene variant in Alzheimer’s disease
2008
GSK3β genetic variability in patients with Multiple Sclerosis
2011
Intrathecal levels of IL-6, IL-11 and LIF in Alzheimer's disease and frontotemporal lobar degeneration
2008
Neuronal nitric oxide synthase C276T polymorphism increases the risk for frontotemporal lobar degeneration
2007
Simultaneous overexpression of human E5NT and ENTPD1 protects porcine endothelial cells against H2O2-induced oxidative stress and cytotoxicity in vitro
2017
Expression and genetic analysis of miRNAs involved in CD4+ cell activation in patients with multiple sclerosis
2011
Is KIF24 a genetic risk factor for Frontotemporal Lobar Degeneration?
2010
The NOS3 G894T (Glu298Asp) polymorphism is a risk factor for frontotemporal lobar degeneration
2008
Expression and Genetic Analysis of MicroRNAs Involved in Multiple Sclerosis
2013
A Novel MAPT Mutation Associated with the Clinical Phenotype of Progressive Nonfluent Aphasia
2011
Circulating miRNAs as Potential Biomarkers in Alzheimer's Disease
2014
Rs5848 Variant Influences GRN mRNA Levels in Brain and Peripheral Mononuclear Cells in Patients with Alzheimer's Disease
2009
MCP-1 A-2518G Polymorphism: Effect on Susceptibility for Frontotemporal Lobar Degeneration and on Cerebrospinal Fluid MCP-1 Levels
2009
Progranulin gene variability influences the risk for bipolar I disorder, but not bipolar II disorder
2014
From Genotype to Phenotype: Two Cases of Genetic Frontotemporal Lobar Degeneration with Premorbid Bipolar Disorder
2011
Antioxidants in Alzheimer’s Disease: Current Therapeutic Significance and Future Prospects
2022